Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer

European Journal of Cancer

Volumn 36, Issue 5, 2000, Pages 601-609

  Yano, T ^a   Tanikawa, S ^a   Fujie, T ^a   Masutani, M ^a   Horie, T ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; CD34; Non small cell lung cancer (NSCLC); Vascular endothelial growth factor (VEGF); von Willebrand factor (vWf)

Indexed keywords

BIOCHEMICAL MARKER; CD34 ANTIGEN; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ADENOCARCINOMA; ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

AGED; ANTIGENS, CD34; CARCINOMA, NON-SMALL-CELL LUNG; ENDOTHELIAL GROWTH FACTORS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0034056981     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00327-5     Document Type: Article

References (40)

1. Folkman J. Tumor angiogenesis. Adv. Cancer Res. 43:1985;175-203.
2. Toi M., Kondo S., Suzuki H.et al. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer. 77:1996;1101-1106.
3. Paley P.J., Staskus K.A., Gebhard K.et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 80:1997;98-106.
4. Takahashi Y., Susan L.T., Kitadai Y.et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch. Surg. 132:1997;541-546.
5. Eisma R.J., Spiro J.D., Kreutzer D.L. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma. Am. J. Surg. 174:1997;513-517.
6. Samoto K., Ikezaki K., Ono M.et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 55:1995;1189-1193.
7. Fontanini G., Bigini D., Vignati S.et al. Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J. Pathol. 177:1995;57-63.
8. Yamazaki K., Abe S., Takekawa H.et al. Tumor angiogenesis in human lung adenocarcinoma. Cancer. 74:1994;2245-2250.
9. Yuan A., Yang P.H., Yu C.J. Tumor angiogenesis correlates with histologic type and metastasis in non-small-cell lung cancer. Am. J. Respir. Crit. Care Med. 152:1995;2157-2162.
10. Ohta Y., Watanabe Y., Oda M.et al. Vascular endothelial growth factor-121 mRNA expression and neomicrovessel density in primary lung cancer. Oncol. Rep. 3:1996;713-717.
11. Mattern J., Koomagi R., Volm M. Vascular endothelial growth factor expression and angiogenesis in non-small cell carcinomas. Int. J. Oncol. 6:1995;1059-1062.
12. Jefferson M.F., Pendleton N., Faragher E.B., Dixon G.R., Myskow M.W., Horan M.A. 'Tumor volume' as a predictor of survival after resection of non-small-cell lung cancer (NSCLC). Br. J. Cancer. 74:1996;456-459.
13. Chandrachud L.M., Pendleton N., Chisholm D.M., Schor A.M. Relationship between vascularity, age and survival in non-small-cell lung cancer. Br. J. Cancer. 76:1996;1367-1375.
14. Pastorino U., Andreola S., Tagliabue E.et al. Immunocytochemical markers in stage I lung cancer. relevance to prognosis J. Clin. Oncol. 15:1997;2858-2865.
15. Fina L., Molgaard H.V., Robertson D.et al. Expression of the CD34 gene in vascular endothelial cells. Blood. 75:1990;2417-2426.
16. Kuzu I., Bicknell R., Harris A.L., Jones M., Gatter K.C., Mason D.Y. Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J. Clin. Pathol. 45:1992;143-148.
17. Wang J.M., Kumar S., Pye D., van Agthoven A.J., Krupinski J., Hunter R.D. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int. J. Cancer. 54:1993;363-370.
18. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1991;1-8.
19. Schlingemann R.O., Rietveld F.J.R., Kwaspen F., van de Kerkhof P.C.M., de Waal R.M.W., Ruiter D.J. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am. J. Pathol. 138:1991;1335-1347.
20. Senger D.R., van de Walter L., Brown L.F.et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:1993;303-324.
21. Ferrara N., Houck K., Jakeman L., Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Rev. 13:1992;18-32.
22. Cohen T., Nahari D., Cerem L.W., Neufeld G., Levi B.Z. Interleukin-6 induced the expression of vascular endothelial growth factor. J. Biol. Chem. 271:1996;736-741.
23. Frank S., Hubner G., Breiner G., Longaker M.T., Greenhalgh D.G., Werner S. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implication for normal and impaired wound healing. J. Biol. Chem. 270:1995;12607-12613.
24. Van Hoef M.E.H.M., Knox W.F., Dhesi S.S., Howell A., Schor A.M. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur. J. Cancer. 29A:1993;1141-1145.
25. Querrec A.L., Duval D., Tobelem G. Tumor angiogenesis. Bailliere's Clin. Haematol. 6:1993;711-730.
26. Watt S.M., Karhi K., Gatter K. Distribution and epitope analysis of the cell membrane glycoprotein (HPCA-1) associated with human hematopoietic progenitor cells. Leukemia. 1:1987;417-426.
27. Young P.E., Baumhueter S., Lasky L. The sialomucin CD34 is expressed on hematopoietic cells and blood vessels during murine development. Blood. 85:1995;96-105.
28. Schlingemann R.O., Rietveld F.J.R., de Waal R.M.W.et al. Leukocyte antigen CD34 is expressed by a subset of cultured endothelial cells and on endothelial abluminal microprocesses in the tumor stroma. Lab. Invest. 62:1990;690-696.
29. Traweek S.T., Kandalaft P.L., Mehta P., Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Anatomic. Pathol. 96:1991;25-31.
30. Fontanini G., Vignati S., Bigini D.et al. Neoangiogenesis. a putative marker of malignancy in non-small-cell lung cancer (NSCLC) development Int. J. Cancer. 67:1996;615-619.
31. Tanigawa N., Amaya H., Matsumura M.et al. Metastasis in gastric carcinomas. Cancer Res. 56:1996;2671-2676.
32. Tanigawa N., Matsumura M., Amaya H.et al. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer. 79:1997;220-225.
33. Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 77:1996;1722-1728.
34. Giatromanolaki A., Koukourakis M., O'Byrne K.et al. Prognostic value of angiogenesis in operable non-small cell lung cancer. J. Pathol. 179:1996;80-88.
35. Horak E.R., Leek R., Klenk N.et al. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet. 340:1992;1120-1124.
36. Bosari S., Lee A.K.C., Delellis R.A., Wiley B.D., Heatley G.J., Silverman M.L. Microvessel quantitation and prognosis in invasive breast carcinoma. Human Pathol. 23:1992;755-761.
37. Maeda K., Chung Y.S., Takatsuka S.et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J. Clin. Oncol. 13:1995;477-481.
38. Kaku T., Kamura T., Kinukawa N.et al. Angiogenesis in endometrial carcinoma. Cancer. 80:1999;741-747.
39. Ohta Y., Watanabe Y., Murakami S.et al. Vascular endothelial growth factor and lymph node metastasis in primary lung cancer. Br. J. Cancer. 76:1997;1041-1045.
40. Volm M., Koomagi R., Mattern J., Stammler G. Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationship to drug response in vitro. Anticancer Res. 17:1997;99-104.